Home  >  Research  >  Labs  >  Cancer Program

OVERVIEW

The Cancer Program is led by Associate Professor Pilar Blancafort.

Perkins researchers have made major discoveries in the field of cancer including uncovering the SLIRP gene which controls hormone production in breast and prostate cancers, the tumour suppressor gene HLS5 and a process for normalising blood vessels in tumours to allow more effective absorption of cancer-combating drugs. Detailed information about our cancer laboratories can be found below.

Associate Professor Pilar Blancafort

Associate Professor Pilar Blancafort

Cancer Epigenetics (Program Head - Cancer)

Read more

RESEARCH NEWS & EVENTS

WA’s Brightest Minds Recognised through the 2024 Aspire Awards

Associate Professor Elena Juan Pardo, a researcher at the Harry Perkins Institute of Medical Research, is among ten Western Australian recipients of the Business Events Perth 2024 Aspire Awards. The…

Read More

New Study Traces Childhood Leukaemia to Genetic Origins Present at Birth

A groundbreaking study has revealed a genetic signpost present in blood samples taken at birth that could determine whether or not that child will later develop the most common form…

Read More
L-r Prof Nigel Laing AO, Emma Weatherley, Associate Professor Gina Ravenscroft

Perth gains NATA-accreditation for rare disease diagnostic tool

Researchers at Perth’s Harry Perkins Institute of Medical Research and PathWest Laboratory Medicine WA are celebrating the long-awaited nationally recognised accreditation of a world-leading diagnostic technology that will provide faster,…

Read More

Help WA's best medical researchers beat the world's toughest diseases.